Nicotine: The link between cigarette smoking and the progression of renal injury?

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 292, Issue 1, 2007, Pages

  Jaimes, Edgar A ^a,b   Tian, Run Xia ^a   Raij, Leopoldo ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cell proliferation; Extracellular matrix; Glomerular mesangium; Reactive oxygen species

Indexed keywords

APOCYNIN; BUNGAROTOXIN RECEPTOR; DIPHENYLIODONIUM SALT; FIBRONECTIN; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA 4; NICOTINIC RECEPTOR ALPHA5; NICOTINIC RECEPTOR BETA2; NICOTINIC RECEPTOR BETA3; NICOTINIC RECEPTOR BETA4; OXIDOREDUCTASE INHIBITOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR RISK; CELL PROLIFERATION; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; KIDNEY INJURY; MESANGIUM CELL; PRIORITY JOURNAL;

CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KIDNEY DISEASES; MESANGIAL CELLS; NICOTINE; REACTIVE OXYGEN SPECIES; RECEPTORS, NICOTINIC; SMOKING; TARS;

EID: 33846316383     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00693.2006     Document Type: Article

References (53)

1. Aronow WS, Dendinger J, and Rokaw SN. Heart rate and carbon monoxide level after smoking high, low-, and non-nicotine cigarettes. A study in male patients with angina pectoris. Ann Intern Med 74: 697-702, 1971.
2. Arredondo J, Hall LL, Ndoye A, Nguyen VT, Chernyavsky AI, Bercovich D, Orr-Urtreger A, Beaudet AL, and Grando SA. Central role of fibroblast alpha3 nicotinic acetylcholine receptor in mediating cutaneous effects of nicotine. Lab Invest 83: 207-225, 2003.
3. Bleyer AJ, Shemanski LR, Burke GL, Hansen KJ, and Appel RG. Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population. Kidney Int 57: 2072-2079, 2000.
4. Boyle P. Cancer, cigarette smoking and premature death in Europe: a review including the Recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996. Lung Cancer 17: 1-60, 1997.
5. Chapman AB, Johnson AM, Gabow PA, and Schrier RW. Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5: 1349-1354, 1994.
6. Choudhury GG, Karamitsos C, Hernandez J, Gentilini A, Bardgette J, and Abboud HE. PI-3-kinase and MAPK regulate mesangial cell proliferation and migration in response to PDGF. Am J Physiol Renal Physiol 273: F931-F938, 1997.
7. Gotti C, and Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 74: 363-396, 2004.
8. Grando SA, Horton RM, Pereira EF, Diethelm-Okita BM, George PM, Albuquerque EX, and Conti-Fine BM. A nicotinic acetylcholine receptor regulating cell adhesion and motility is expressed in human keratinocytes. J Invest Dermatol 105: 774-781, 1995.
9. Grassi G, Seravalle G, Calhoun DA, Bolla GB, Giannattasio C, Marabini M, Del Bo A, and Mancia G. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 90: 248-253, 1994.
10. Guo J, Chu M, Abbeyquaye T, and Chen CY. Persistent nicotine treatment potentiates amplification of the dihydrofolate reductase gene in rat lung epithelial cells as a consequence of Ras activation. J Biol Chem 280: 30422-30431, 2005.
11. Halimi JM, Giraudeau B, Vol S, Caces E, Nivet H, and Tichet J. The risk of hypertension in men: direct and indirect effects of chronic smoking. J Hypertens 20: 187-193, 2002.
12. Halimi JM, Philippon C, and Mimran A. Contrasting renal effects of nicotine in smokers and non-smokers. Nephrol Dial Transplant 13: 940-944, 1998.
13. Hartsough MT, and Mulder KM. Transforming growth factor beta activation of p44mapk in proliferating cultures of epithelial cells. J Biol Chem 270: 7117-7124, 1995.
14. Heeschen C, Jang JJ, Weis M, Pathak A, Kaji S, Hu RS, Tsao PS, Johnson FL, and Cooke JP. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 7: 833-839, 2001.
15. Heeschen C, Weis M, Aicher A, Dimmeler S, and Cooke JP. A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest 110: 527-536, 2002.
16. Horner D, Fliser D, Klimm HP, and Ritz E. Albuminuria in normotensive and hypertensive individuals attending offices of general practitioners. J Hypertens 14: 655-660, 1996.
17. Jaimes EA, DeMaster EG, Tian RX, and Raij L. Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler Thromb Vasc Biol 24: 1031-1036, 2004.
18. Jaimes EA, Galceran JM, and Raij L. Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 54: 775-784, 1998.
19. Jaimes EA, Galceran JM, and Raij L. Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 54: 775-784, 1998.
20. Jaimes EA, Nath KA, and Raij L. Hydrogen peroxide downregulates IL-1-driven mesangial iNOS activity: implications for glomerulonephritis. Am J Physiol Renal Physiol 272: F721-F728, 1997.
21. Jaimes EA, Tian RX, Pearse D, and Raij L. Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species. Kidney Int 68: 2143-2153, 2005.
22. Jiang Z, Seo JY, Ha H, Lee EA, Kim YS, Han DC, Uh ST, Park CS, and Lee HB. Reactive oxygen species mediate TGF-beta1-induced plasminogen activator inhibitor-1 upregulation in mesangial cells. Biochem Biophys Res Commun 309: 961-966, 2003.
23. Lukas RJ, and Bencherif M. Heterogeneity and regulation of nicotinic acetylcholine receptors. Int Rev Neurobiol 34: 25-131, 1992.
24. Macklin KD, Maus AD, Pereira EF, Albuquerque EX, and Conti-Fine BM. Human vascular endothelial cells express functional nicotinic acetylcholine receptors. J Pharmacol Exp Ther 287: 435-439, 1998.
25. Mann SJ, James GD, Wang RS, and Pickering TG. Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case-control study. JAMA 265: 2226-2228, 1991.
26. Maus AD, Pereira EF, Karachunski PI, Horton RM, Navaneetham D, Macklin K, Cortes WS, Albuquerque EX, and Conti-Fine BM. Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors. Mol Pharmacol 54: 779-788, 1998.
27. McBride PE. The health consequences of smoking. Cardiovascular diseases. Med Clin North Am 76: 333-353, 1992.
28. Mimran A, Ribstein J, DuCailar G, and Halimi JM. Albuminuria in normals and essential hypertension. J Diabetes Complications 8: 150-156, 1994.
29. Minami J, Ishimitsu T, and Matsuoka H. Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension 33: 586-590, 1999.
30. Ohba M, Shibanuma M, Kuroki T, and Nose K. Production of hydrogen peroxide by transforming growth factor-beta 1. J Cell Biol 126: 1079-1088, 1994.
31. Orth SR. Smoking - a renal risk factor. Nephron 86: 12-26, 2000.
32. Orth SR, Stockmann A, Conradt C, Ritz E, Ferro M, Kreusser W, Piccoli G, Rambausek M, Roccatello D, Schafer K, Sieberth HG, Wanner C, Watschinger B, and Zucchelli P. Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 54: 926-931, 1998.
33. Orth SR, Viedt C, and Ritz E. Adverse effects of smoking in the renal patient. Tohoku J Exp Med 194: 1-15, 2001.
34. Pontieri FE, Tanda G, Orzi F, and Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382: 255-257, 1996.
35. Poulsen PL, Ebbehoj E, Hansen KW, and Mogensen CE. Effects of smoking on 24-h ambulatory blood pressure and autonomic function in normoalbuminuric insulin-dependent diabetes mellitus patients. Am J Hypertens 11: 1093-1099, 1998.
36. Raij L, DeMaster EG, and Jaimes EA. Cigarette smoke-induced endothelium dysfunction: role of superoxide anion. J Hypertens 19: 891-897, 2001.
37. Regalado M, Yang S, and Wesson DE. Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension. Am J Kidney Dis 35: 687-694, 2000.
38. Ritz E, Benck U, Franek E, Keller C, Seyfarth M, and Clorius J. Effects of smoking on renal hemodynamics in healthy volunteers and in patients with glomerular disease. J Am Soc Nephrol 9: 1798-1804, 1998.
39. Ritz E, Benck U, and Orth SR. Acute effects of cigarette smoking on renal hemodynamics. Contrib Nephrol 130: 31-38, 2000.
40. Roman J, Ritzenthaler JD, Gil-Acosta A, Rivera HN, and Roser-Page S. Nicotine and fibronectin expression in lung fibroblasts: implications for tobacco-related lung tissue remodeling. FASEB J 18: 1436-1438, 2004.
41. Rossing P, Hougaard P, and Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diabetes Care 25: 859-864, 2002.
42. Sano M, Fukuda K, Sato T, Kawaguchi H, Suematsu M, Matsuda S, Koyasu S, Matsui H, Yamauchi-Takihara K, Harada M, Saito Y, and Ogawa S. ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts. Circ Res 89: 661-669, 2001.
43. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, and Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 91: 406-413, 2002.
44. Sharma P, Evans AT, Parker PJ, and Evans FJ. NADPH-oxidase activation by protein kinase C-isotypes. Biochem Biophys Res Commun 177: 1033-1040, 1991.
45. Stegmayr BG. A study of patients with diabetes mellitus (type 1) and end-stage renal failure: tobacco usage may increase risk of nephropathy and death. J Intern Med 228: 121-124, 1990.
46. Stengel B, Couchoud C, Cenee S, and Hemon D. Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies. Kidney Int 57: 2519-2526, 2000.
47. 2 for platelet-derived growth signal transduction. Science 270: 296-299, 1995.
48. Tharaux PL, Chatziantoniou C, Fakhouri F, and Dussaule JC. Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway. Hypertension 36: 330-336, 2000.
49. Tian W, Zhang Z, and Cohen DM. MAPK signaling and the kidney. Am J Physiol Renal Physiol 279: F593-F604, 2000.
50. Urakawa N, Nagata T, Kudo K, Kimura K, and Imamura T. Simultaneous determination of nicotine and cotinine in various human tissues using capillary gas chromatography/mass spectrometry. Int J Legal Med 106: 232-236, 1994.
51. Ward MM, and Studenski S. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Arch Intern Med 152: 2082-2088, 1992.
52. Wessler I, Kirkpatrick CJ, and Racke K. The cholinergic 'pitfall': acetylcholine, a universal cell molecule in biological systems, including humans. Clin Exp Pharmacol Physiol 26: 198-205, 1999.
53. Ye YN, Liu ES, Shin VY, Wu WK, and Cho CH. The modulating role of nuclear factor-kappaB in the action of alpha7-nicotinic acetylcholine receptor and cross-talk between 5-lipoxygenase and cyclooxygenase-2 in colon cancer growth induced by 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1- butanone. J Pharmacol Exp Ther 311: 123-130, 2004.